| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.6 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Paul L. Daniels Ebola 0.1.4. It has been rated as critical. This affects an unknown part. Performing a manipulation results in code injection. In addition, an exploit is available. Upgrading the affected component is advised.
Details
A vulnerability classified as critical has been found in Paul L. Daniels Ebola 0.1.4. This affects an unknown function. The manipulation with an unknown input leads to a code injection vulnerability. CWE is classifying the issue as CWE-94. The product constructs all or part of a code segment using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the syntax or behavior of the intended code segment. This is going to have an impact on confidentiality, integrity, and availability.
The weakness was presented 12/05/2003 with Secure Network Operations, Inc.. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. Technical details are unknown but a public exploit is available. MITRE ATT&CK project uses the attack technique T1059 for this issue.
A public exploit has been developed in ANSI C. The exploit is shared for download at securityfocus.com. It is declared as proof-of-concept. The vulnerability scanner Nessus provides a plugin with the ID 11946 (Ebola AV Daemon < 0.1.5 Authentication Sequence Remote Overflow), which helps to determine the existence of the flaw in a target environment. It is assigned to the family Gain a shell remotely and running in the context r.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the databases at X-Force (13909), Tenable (11946), SecurityFocus (BID 9156†) and Vulnerability Center (SBV-3223†). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.3VulDB Meta Temp Score: 6.6
VulDB Base Score: 7.3
VulDB Temp Score: 6.6
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Code injectionCWE: CWE-94 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Programming Language: 🔍
Download: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 11946
Nessus Name: Ebola AV Daemon < 0.1.5 Authentication Sequence Remote Overflow
Nessus File: 🔍
Nessus Risk: 🔍
Nessus Family: 🔍
Nessus Context: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
SourceFire IPS: 🔍
Timeline
12/05/2003 🔍12/05/2003 🔍
12/05/2003 🔍
12/10/2003 🔍
12/18/2003 🔍
07/10/2016 🔍
09/01/2022 🔍
Sources
Organization: Secure Network Operations, Inc.Status: Not defined
GCVE (VulDB): GCVE-100-88893
X-Force: 13909
SecurityFocus: 9156 - PLD Software Ebola Buffer Overflow Vulnerability
Vulnerability Center: 3223 - Ebola 0.1.4 Allows Code Execution, High
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 07/10/2016 23:26Updated: 09/01/2022 09:45
Changes: 07/10/2016 23:26 (55), 02/21/2019 12:34 (2), 09/01/2022 09:45 (2)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.